Market Research Logo

Drug Delivery Markets: Implantable / Injectable and Needle-Free Delivery Systems

With pharmaceutical companies increasingly looking for ways to extend the revenue-earning lifetime of their biggest products, drug delivery has become an important focus of the industry. Kalorama’s Drug Delivery Markets: Implantable / Injectable and Needle-Free Delivery Systems provides detail for business planners on the market for implantable / injectable delivery system markets.

Biopharmaceutical products are driving growth of needle-free systems; there will likely be significant increases in revenues in the vaccine arena. This report looks at that trend and reports current and forecasted revenues for the implantable/injectable drug delivery market, segmented into two main categories:

  • Needle-free drug delivery
  • Other Injectable/Implantable
Kalorama's unique analysis offers segmentation of this market for:
  • Drug Delivery Technology Revenues
  • Pharmaceuticals Sold via Delivery Technology
This breakout makes the report relevant to business plans of either device technology companies or pharmaceutical concerns. (This market analysis does not include drug-eluding stents or prefilled or regular syringes. Kalorama considers these separate markets)

The report covers both pharmaceuticals sold through implantable/injectable delivery systems and the technologies themselves including:

  • Detailed Profiles of Key Companies in Implantable/Injectable Delivery
  • Brief Round-Up of Smaller Players
  • Current Market Size and Forecasts to 2013
  • Needle-Free Cost Savings, Protein-Coated Microcrystal Technology, Nanotechnology, and Other Trends and Developments
  • Revenue Forecasts
  • New Products in Development
Kalorama’s trusted information-gathering process provides most accurate study of the implantable/injectable delivery drug market available today. Information and analysis presented in this report is based on extensive interviews with senior management of top companies in the industry. While major research literature and government information is culled, information is corroborated and key market insights originate from interviews with industry leaders.


New York, September 10, 2009 - Many of the novel biopharmaceutical drugs developed now can only be delivered by injection, and this has biologic manufacturers seeking out the most patient-friendly options, including needle-free systems. According to healthcare market research firm Kalorama Information, this trend has helped fuel a $2.7 billon market for pharmaceutical products combined with needle-free technology. In its report Drug Delivery Markets: Implantable / Injectable and Needle-Free Systems, Kalorama says a recent convergence of synthetic materials and computerized design software will propel the market for such product delivery systems to 9.7% annual growth over the next five years.

“Three fourths of biopharmaceuticals cannot be delivered orally,” said Mary Ann Crandall, Kalorama Information’s drug delivery analyst. “Using a needle-free injection has been shown to reduce needlestick injuries, increase compliance and eliminate the need for disposal, all advantages that will help sales.”

Most needle-free jet injectors use metal springs, compressed air, or CO2 gas to power the injection. The device's nozzle is held against the patient's skin and, once activated, injects a fine stream of the drug into the skin at a high pressure.

In the United States, more than a dozen needle-free jet injectors have been licensed by the Food and Drug Administration and are on the market. The VitaJet, made by Bioject, has long been used by diabetes patients. The Biojector 2000 is a popular system for vaccine delivery, the SeroJet has been used for delivering hormone treatments for HIV-associated wasting, and the PenJet has been used for multiple applications. Product developer Antares Pharma and Teva Pharmaceutical announced recently a new needle-free injector system called Tjet used to administer the growth hormone product Tev-Tropin to children.

“Delivery is considered crucial to the marketing strategy of drugs,” Crandall said. “Needle-free has been a part of insulin marketing for some time and now we are also seeing it with vaccines and protein treatments.”

More information on needle-free systems can be found in Kalorama Information’s new report Drug Delivery Markets: Implantable / Injectable and Needle-Free Systems, which provides an in-depth breakdown of the global market for these devices. A market summary includes a total market analysis, key product summary, forecasts and a competitive analysis of leading companies.

About Kalorama Information
Kalorama Information supplies the latest in independent market research in the life sciences, as well as a full range of custom research services.

  • Executive Summary
    • MARKET DRIVERS
    • MARKET SIZE AND GROWTH
      • Total Implantable/Injectable Drug Delivery Market
      • The Implantable/Injectable Drug Delivery Only Market
    • COMPETITOR AND MARKET ANALYSIS
  • Introduction
    • SCOPE AND METHODOLOGY
    • REASONS FOR INJECTABLE/IMPLANTABLE DRUG DELIVERY SYSTEMS
    • HISTORY OF INJECTABLE/IMPLANTABLE DRUG DELIVERY
    • PHASES OF DRUG ACTION
      • Table Sequence of Drug Action
    • NEEDLE-FREE DRUG DELIVERY
      • Major Applications
      • Safety Concerns
      • Products
    • IMPLANTABLE DRUG DELIVERY
      • Mechanisms
      • Applications
      • Products
    • SUSTAINED-RELEASE DRUG DELIVERY
      • Products
    • TARGETED INJECTION DRUG DELIVERY
      • Products
        • Table Marketed Products Using Liposomal Drug Delivery
        • Table Marketed Products Using Nanoparticle Drug Delivery
  • Trends and Developments
    • DRIVERS OF THE IMPLANTABLE/INJECTABLE DRUG DELIVERY MARKET
    • PEN INJECTORS
    • PROPRIETARY PRODUCT DEVELOPMENT
    • DELIVERY SYSTEMS PLACEMENT TRENDS
    • THERAPEUTIC TRENDS
    • INCORPORATION OF TECHNOLOGY
    • NANOTECHNOLOGY
    • DRUG DELIVERY DEVELOPMENT
      • Microsphere Technology
      • Targeted Technology
      • MicroChip Technology
      • Protein-Coated Microcrystal Technology
      • Needle-Free Delivery Development
      • Selected Products in Development
        • Table Select Products in Development by Drug Delivery Companies
  • Market Size and Growth
    • THE TOTAL IMPLANTABLE/INJECTABLE DRUG DELIVERY MARKET
      • Table The Worldwide Market for Implantable/Injectable Drug Delivery Technology and Pharmaceuticals 2003-2013
      • Table The Worldwide Market for Pharmaceuticals Utilizing Injectable/Implantable Drug Delivery by Type 2003-2013
      • Table The Worldwide Market for Pharmaceuticals Utilizing Injectable/Implantable Drug Delivery Market Share by Type 2003-2013
    • INJECTABLE/IMPLANTABLE DELIVERY TECHNOLOGY ONLY MARKET
      • Table The Worldwide Market for Injectable/Implantable Drug Delivery Systems by Pharmaceutical and Drug Delivery Component 2003-2013
      • Table The Worldwide Market for Injectable/Implantable Drug Delivery Systems Distribution of Revenue by Pharmaceutical and Drug Delivery Component 2003-2013
  • Competitive and Market Analysis
    • COMPETITIVE LANDSCAPE
      • Table Leading Suppliers of Implantable/Injectable Drug Delivery Technology
    • MARKET ANALYSIS
  • Company Profiles
    • ALKERMES, INC.
    • ALZA CORP.
    • ANTARES PHARMA, INC.
    • BIOJECT MEDICAL TECHNOLOGIES, INC.
    • CYDEX, INC.
    • MGI PHARMA, INC
    • NEKTAR THERAPEUTICS
    • PACIRA PHARMACEUTICALS, INC.
    • PSIVIDA
    • SURMODICS, INC
    • ZOGENIX CORPORATION
  • Companies in Brief
    • AP PHARMA
    • BAXTER BIOPHARMA SOLUTIONS
    • QLT USA, INC
    • YPSOMED HOLDING AG
  • Company Directory

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report